Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

Patent 12083121 was granted and assigned to Amgen on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shon Booker0

Nobuko Nishimura0

Ana Elena Minatti0

Victor J. Cee0

Longbin Liu0

Thomas T. Nguyen0

Jennifer Rebecca Allen0

Ning Chen0

...

Date of Patent

September 10, 2024

0

Patent Application Number

175793590

Date Filed

January 19, 2022

0

Patent Citations

US Patent 7700636 Thiadiazole compounds and methods of use

0

US Patent 7812135 GITR-binding antibodies

0

US Patent 7897619 Heterocyclic modulators of PKB

0

US Patent 7919504 Thiadiazole modulators of PKB

0

US Patent 7919514 Thiadiazole compounds and methods of use

0

US Patent 7025962 Mammalian cell surface antigens; related reagents

0

US Patent 7354944 Thiadiazole compounds and methods of use

0

US Patent 7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases

0

...

Patent Primary Examiner

Douglas M Willis

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool